In order to observe the curative and side effects in malignant hematologic diseases treated with autologous peripheral blood stem cell transplantation (auto PBSCT) combined with halotype lymphocyte infusion, auto PBSCs were mobilized, harvested and stored at -196℃ from patients in first CR or PR with intensive chemotherapy (Ara C 1.0 g/m 2×5 days or cyclophosphamide 60 mg/kg×2 days) and G CSF. Unpurged auto PBSCs were infused when patients recieved the conditioning regimen with busulfan, total irradia...